Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $321
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $281 to $321.
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $281 to $321.